Deciphering the Genetic Architecture of Autoimmune Diseases | MicrobiomeTrials← Back to trialsNCT06948110
Deciphering the Genetic Architecture of Autoimmune Diseases
RecruitingOBSERVATIONAL
Trial Details
Start: 2026-06-14Est. Completion: 2030-04-22
Enrollment target: 300 participants Locations- National Human Genome Research Institute (NHGRI), Bethesda, Maryland, United States
- Amazon Rainforest, Lima, Peru
Other microbiome trials you might be interested in
Vaccine ReactionZosterSystemic Lupus Erythematosus
The goal of this observational study is to compare the vaccine response to the 2 doses of the adjuvanted herpes zoster s…
Seoul, South KoreaEst. completion Oct 1, 2030
Diabetes Mellitus, Type 1Hypoglycemia Unawareness
This is a prospective randomized placebo-controlled double-blind crossover pilot study determining the effect of dichlor…
New Haven, United StatesEst. completion May 1, 2027
Phase 1
Recruiting
Refractory/Relapsed Systemic Lupus ErythematosusRefractory / Relapsed / Progressive Systemic SclerosisRefractory / Relapsing / Progressive Inflammatory MyopathyRefractory / Relapsed Anti-Neutrophil Cytoplasmic Antibody (ANCA)-Associated VasculitisRefractory / Relapsed Connective Tissue Disease-Associated Thrombocytopenia
This study is a single-arm, intervention, dose-escalation clinical trial to evaluate the safety of allogeneic CD19/BCMA-…
Multiple LocationsEst. completion Dec 31, 2028